Citation Impact
Citing Papers
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054
2019
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
2011
Defining and measuring gender: A social determinant of health whose time has come
2005
De novo design of immunoglobulin-like domains
2022 StandoutNobel
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
2003
The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients
2011
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
2010
Gender difference in ifosfamide metabolism by human liver microsomes
2001
Inhaled Corticosteroids
2003
Parkinson's disease
2021 Standout
Global health burden and needs of transgender populations: a review
2016 Standout
Plasma Proteome Profiling to Assess Human Health and Disease
2016
Ovarian cancer
2014 Standout
Antibody engineering and modification technologies
2007
The Influence of Pharmacogenetics on the Time to Achieve Target Tacrolimus Concentrations after Kidney Transplantation
2004
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
Loading of Vesicles into Soft Amphiphilic Nanotubes using Osmosis
2015 StandoutNobel
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
2001
Asthma
2017 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia
2008
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
2010
Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis
2014
Crohn's disease
2016 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Type 2 diabetes
2017 Standout
Therapeutic implications of the gender-specific aspects of cardiovascular disease
2006
Tadalafil: A Long-Acting Phosphodiesterase-5 Inhibitor for the Treatment of Pulmonary Arterial Hypertension
2011
Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®
2001
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
2010
Selective gas adsorption and separation in metal–organic frameworks
2009 Standout
Significance of the Minor Cytochrome P450 3A Isoforms
2006
A thermostable Cas9 with increased lifetime in human plasma
2017 StandoutNobel
Idarucizumab for Dabigatran Reversal
2015 Standout
A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran
2015
Advances in the development of new tuberculosis drugs and treatment regimens
2013
Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment
2016
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Mesoporous Materials for Drug Delivery
2007 Standout
Antibiotic dosing in children in Europe
2012
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
2007
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Gender differences in drug responses
2006
Do Inhaled Corticosteroids Inhibit Growth in Children?
2001
Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
2010 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients With Cancer Based on the Modeling of Preclinical and Clinical Pharmacokinetic and Pharmacodynamic Data
2008
Controlled-Access Hollow Mechanized Silica Nanocontainers
2009 StandoutNobel
Effect of a New FunctionalCYP3A4Polymorphism on Calcineurin Inhibitors‘ Dose Requirements and Trough Blood Levels in Stable Renal Transplant Patients
2011
Sex Differences in Pharmacokinetics and Pharmacodynamics
2004
The emerging role of computational design in peptide macrocycle drug discovery
2020
Strategies for the Conversion of Lignin to High-Value Polymeric Materials: Review and Perspective
2015 Standout
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
2015
The Current State of Peptide Drug Discovery: Back to the Future?
2017
Hydrogels for Protein Delivery
2012
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure
2016
Sex differences in the psychopharmacological treatment of depression
2016
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
2019
A Growing Role for Gender Analysis in Air Pollution Epidemiology
2009
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves
2010 StandoutNobel
Multiple Sclerosis
2018 Standout
Strategies for extended serum half-life of protein therapeutics
2011
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Phase I/II Study of the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Patients with Relapsed or Refractory Hematologic Malignancies
2006
Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver
2003
Capacity limits of asialoglycoprotein receptor-mediated liver targeting
2017
Mesoporöse Materialien für den Wirkstofftransport
2007
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
A growing role for gender analysis in air pollution epidemiology
2011
Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1
2021 StandoutNobel
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
2014
Palladium–Silver Cooperativity in an Aryl Amination Reaction through C–H Functionalization
2015
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Catalytic Asymmetric Synthesis of Unprotected β2-Amino Acids
2021 StandoutNobel
Cytochrome P4503APolymorphisms and Immunosuppressive Drugs: An Update
2007
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
2018
Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions
2016
Dissecting Alkynes: Full Cleavage of Polarized C≡C Moiety via Sequential Bis-Michael Addition/Retro-Mannich Cascade
2011
Light-Operated Mechanized Nanoparticles
2009 StandoutNobel
Using Genetic and Clinical Factors to Predict Tacrolimus Dose in Renal Transplant Recipients
2010
Influence of Constitution and Charge on Radical Pairing Interactions in Tris-radical Tricationic Complexes
2016 StandoutNobel
Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized Nanoparticles
2010 StandoutNobel
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis
2020 StandoutNobel
Transition Metal-Catalyzed C–H Amination: Scope, Mechanism, and Applications
2017 Standout
Integration of Porous Coordination Polymers and Gold Nanorods into Core–Shell Mesoscopic Composites toward Light-Induced Molecular Release
2013 StandoutNobel
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Differential Effects of β3‐ versus β2‐Amino Acid Residues on the Helicity and Recognition Properties of Bim BH3‐Derived α/β‐Peptides
2018
Variation in CYP1A2 Activity and its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms
2008
Works of Bernd Meibohm being referenced
Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties
2012
Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate
1996
G2677T and C3435T Genotype and Haplotype Are Associated With HepaticABCB1(MDR1) Expression
2006
Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
2013
The In Silico Child: Using Simulation to Guide Pediatric Drug Development and Manage Pediatric Pharmacotherapy
2009
Pharmacokinetic aspects of biotechnology products
2004
Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration
1998
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents
2008
The challenge of indication extrapolation for infliximab biosimilars
2014
The Clinical Pharmacokinetics of Phosphodiesterase‐5 Inhibitors for Erectile Dysfunction
2005
Pharmacokinetics of immunosuppressants: a perspective on ethnic differences
2004
Strategic Biomarkers for Drug Development in Treating Rare Diseases and Diseases in Neonates and Infants
2013
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
2010
Single‐ and Multiple‐Dose Pharmacokinetics of Pioglitazone in Adolescents With Type 2 Diabetes
2005
How Important Are Gender Differences in Pharmacokinetics?
2002
SYBR Green-based real-time PCR allelic discrimination assay for β2-adrenergic receptor polymorphisms
2005
Characterizing the Impact of Renal Impairment on the Clinical Pharmacology of Biologics
2012
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
2012
Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives
1999
The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients
2003
Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer Agents
2010
Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections
2015
Pharmacokinetics of Anthocyanins and Antioxidant Effects after the Consumption of Anthocyanin-Rich Açai Juice and Pulp (Euterpe oleracea Mart.) in Human Healthy Volunteers
2008
Gender differences in pharmacokinetics and pharmacodynamics.
1999
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids
1998